Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25014687

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2014 Jul 17
First author
Caplin ME

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Endocrinol. 2014 Oct;10(10):577. doi: 10.1038/nrendo.2014.133.
    note
    Source null
    related pmid
    25069467
    relationship
    Comment in
  2. citation
    Cancer Discov. 2014 Oct;4(10):OF3. doi: 10.1158/2159-8290.CD-NB2014-124.
    note
    Source null
    related pmid
    25274694
    relationship
    Comment in
  3. citation
    N Engl J Med. 2014 Oct 16;371(16):1556-7. doi: 10.1056/NEJMc1409757.
    note
    Source null
    related pmid
    25317881
    relationship
    Comment in
  4. citation
    N Engl J Med. 2014 Oct 16;371(16):1555-6. doi: 10.1056/NEJMc1409757.
    note
    Source null
    related pmid
    25317882
    relationship
    Comment in
  5. citation
    N Engl J Med. 2014 Oct 16;371(16):1556. doi: 10.1056/NEJMc1409757.
    note
    Source null
    related pmid
    25317883
    relationship
    Comment in

Authors and identifiers

  1. name
    Caplin ME
    type
    Author
  2. name
    Pavel M
    type
    Author
  3. name
    Ćwikła JB
    type
    Author
  4. name
    Phan AT
    type
    Author
  5. name
    Raderer M
    type
    Author
  6. name
    Sedláčková E
    type
    Author
  7. name
    Cadiot G
    type
    Author
  8. name
    Wolin EM
    type
    Author
  9. name
    Capdevila J
    type
    Author
  10. name
    Wall L
    type
    Author
  11. name
    Rindi G
    type
    Author
  12. name
    Langley A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Caplin ME
    type
    Author
  2. name
    Pavel M
    type
    Author
  3. name
    Ćwikła JB
    type
    Author
  4. name
    Phan AT
    type
    Author
  5. name
    Raderer M
    type
    Author
  6. name
    Sedláčková E
    type
    Author
  7. name
    Cadiot G
    type
    Author
  8. name
    Wolin EM
    type
    Author
  9. name
    Capdevila J
    type
    Author
  10. name
    Wall L
    type
    Author
  11. name
    Rindi G
    type
    Author
  12. name
    Langley A
    type
    Author
bibliography ids
  1. nci-bib-b49f356ef71a983272a4d7ab
book metadata
content sha256
f70717f2389cd456f20006416e81edfc71d4a9a63afbeceb9547578d1c5b2f65
document type
citation
dois
  1. 10.1056/NEJMoa1316158
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:25014687
immutable id
pubmed:25014687@f70717f2389cd456f20006416e81edfc71d4a9a63afbeceb9547578d1c5b2f65
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
3
name
The New England journal of medicine
nlm unique id
0255562
pages
224-33
volume
371
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Endocrinol. 2014 Oct;10(10):577. doi: 10.1038/nrendo.2014.133.
    note
    Source null
    related pmid
    25069467
    relationship
    Comment in
  2. citation
    Cancer Discov. 2014 Oct;4(10):OF3. doi: 10.1158/2159-8290.CD-NB2014-124.
    note
    Source null
    related pmid
    25274694
    relationship
    Comment in
  3. citation
    N Engl J Med. 2014 Oct 16;371(16):1556-7. doi: 10.1056/NEJMc1409757.
    note
    Source null
    related pmid
    25317881
    relationship
    Comment in
  4. citation
    N Engl J Med. 2014 Oct 16;371(16):1555-6. doi: 10.1056/NEJMc1409757.
    note
    Source null
    related pmid
    25317882
    relationship
    Comment in
  5. citation
    N Engl J Med. 2014 Oct 16;371(16):1556. doi: 10.1056/NEJMc1409757.
    note
    Source null
    related pmid
    25317883
    relationship
    Comment in
outcomes validated
false
pmid
25014687
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
094f6a6197e172743cbd6447cfbcc583754d4185654ec6d3c906dca8e2bb8cb0
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Jul 17
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25014687/
title
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Preserved source evidence · Not medical advice